PHARMACEUTICAL PREPARATIONS, NAMELY, STATIN AND L-ARGININE, FOR TREATMENT OF PATIENTS WHO HAVE OR ARE AT RISK OF HAVING NEUROLOGICAL DISORDERS, CARDIO-VASCULAR DISEASE, CEREBRAL VASCULAR ACCIDENTS, OR APOPLEXY; AND PHARMACEUTICAL PREPARATIONS, NAMELY, STATIN AND L-ARGININE PREPARATIONS FOR TREATMENT OF PATIENTS UNDERGOING CABG OR CARDIOVASCULAR SURGERY